Literature DB >> 21810921

Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci.

Sara Pruzina1, Gareth T Williams, Galina Kaneva, Sarah L Davies, Alicia Martín-López, Marianne Brüggemann, Sueli M Vieira, Simon A Jeffs, Quentin J Sattentau, Michael S Neuberger.   

Abstract

Mice carrying human immunoglobulin transloci were immunised with HIV-1 gp140 antigen to gain insight into the range and nature of human monoclonal antibodies (mAbs) that can be elicited from such humanised mice. Using five-feature mice that harbour YAC-based germline-configuration human IgM, Igκ and Igλ transloci in a mouse background disrupted for endogenous mouse IgH and Igκ expression, gp140-specific human IgM mAbs were readily elicited following serial immunisation. These mAbs were converted to human IgG1 format and were found to bind diverse epitopes within gp140, exhibiting high functional affinity for the antigen-typically in the nanomolar or sub-nanomolar range. The number of specific, stable hybridomas per mouse was, however, low (typically around five) with the hybridomas within individual mice often being clonally related. Nevertheless, different mice used B cell clones expressing varied V(D)J combinations, with affinity maturation through somatic hypermutation making a critical contribution. Thus, a wide range of distinct high-affinity mAbs can be obtained by immunising multiple animals. The results confirm the utility of the translocus-mouse approach and give insight into strategies for possible future improvement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810921     DOI: 10.1093/protein/gzr038

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  11 in total

Review 1.  Animal and model systems for studying cystic fibrosis.

Authors:  Bradley H Rosen; Marc Chanson; Lara R Gawenis; Jinghua Liu; Aderonke Sofoluwe; Alice Zoso; John F Engelhardt
Journal:  J Cyst Fibros       Date:  2017-09-19       Impact factor: 5.482

2.  B Cells Carrying Antigen Receptors Against Microbes as Tools for Vaccine Discovery and Design.

Authors:  Deepika Bhullar; David Nemazee
Journal:  Curr Top Microbiol Immunol       Date:  2019-03-28       Impact factor: 4.291

3.  Generation of transgenic mice with megabase-sized human yeast artificial chromosomes by yeast spheroplast-embryonic stem cell fusion.

Authors:  Liangping Li; Thomas Blankenstein
Journal:  Nat Protoc       Date:  2013-07-18       Impact factor: 13.491

Review 4.  Human antibody production in transgenic animals.

Authors:  Marianne Brüggemann; Michael J Osborn; Biao Ma; Jasvinder Hayre; Suzanne Avis; Brian Lundstrom; Roland Buelow
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-12-03       Impact factor: 4.291

5.  Expression of recombinant antibodies.

Authors:  André Frenzel; Michael Hust; Thomas Schirrmann
Journal:  Front Immunol       Date:  2013-07-29       Impact factor: 7.561

6.  Directed evolution of human scFvs in DT40 cells.

Authors:  Alfred W Y Lim; Gareth T Williams; Cristina Rada; Julian E Sale
Journal:  Protein Eng Des Sel       Date:  2015-10-30       Impact factor: 1.650

7.  Antigen-specific single B cell sorting and expression-cloning from immunoglobulin humanized rats: a rapid and versatile method for the generation of high affinity and discriminative human monoclonal antibodies.

Authors:  Laure-Hélène Ouisse; Laetitia Gautreau-Rolland; Marie-Claire Devilder; Michael Osborn; Melinda Moyon; Jonathan Visentin; Frank Halary; Marianne Bruggemann; Roland Buelow; Ignacio Anegon; Xavier Saulquin
Journal:  BMC Biotechnol       Date:  2017-01-09       Impact factor: 2.563

8.  Identifying the Epitope Regions of Therapeutic Antibodies Based on Structure Descriptors.

Authors: 
Journal:  Int J Mol Sci       Date:  2017-11-24       Impact factor: 5.923

9.  High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region.

Authors:  Michael J Osborn; Biao Ma; Suzanne Avis; Ashleigh Binnie; Jeanette Dilley; Xi Yang; Kevin Lindquist; Séverine Ménoret; Anne-Laure Iscache; Laure-Hélène Ouisse; Arvind Rajpal; Ignacio Anegon; Michael S Neuberger; Roland Buelow; Marianne Brüggemann
Journal:  J Immunol       Date:  2013-01-09       Impact factor: 5.422

Review 10.  Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.

Authors:  Juan C Almagro; Tracy R Daniels-Wells; Sonia Mayra Perez-Tapia; Manuel L Penichet
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.